Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Meta-analyses of GLP-1 receptor agonists show that approximately 25% of weight lost consists of lean mass, with 75% coming from fat mass
This gastric emptying effect is most pronounced during initial treatment and tends to attenuate with continued use
When it comes to microdosing GLP-1s, there are a few different ways to interpret it
Retatrutide activates GIP, GLP-1 and glucagon receptors
Treatment may not be suitable for: Pregnancy or breastfeeding Certain medical conditions (assessed during consultation) Current chemotherapy treatment Severe kidney or liver disease How Often Should I Get Treatments
10.1038/nri.2017.52 181 SunC.WuQ.ZhangX.HeQ.ZhaoH
US$ 27.77
US$ 29.33
US$ 27.94
